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Final 1 
Thank you for including me in this illustrious group of speakers. Perhaps I 
should make clear that the title of my talk was furnished by the organizing 
committee. I can only assume that my good friend, John Najarian, came up with 
the resurrection idea. Normally, resurrections require the presence of saviors 
who end up being crucified. Once the facts surrounding our 1984 article (1) are 
revealed, I hope to be stripped of my savior status, or at least the martyrdom. 
The Seminal Lillehei Papers 
Where our 1984 contribution came from is best understood by starting 
with the landmark paper presented by Rich Lillehei to the American Surgical 
Association (ASA) on April 27, 1970 (2). Lillehei briefly mentioned his earlier 
unsuccessful case of segmental pancreas transplantation (with Bill Kelly) (3), 
before getting to his 10 whole organ procedures. Venous drainage from the 
pancreatiocoduodenal grafts was directed into the iliocaval system. In the first 4 
whole organ recipients, exocrine secretions from the pancreas were exteriorized 
with a skin duodenostomy (2). 
In cases 5 through 10, the proximal end of the graft duodenum was 
closed, and the distal duodenum (or adjacent jejunum) was anastomosed as part 
of a composite Roux limb to the host jejunum. In 9 of the 10 cases, a kidney also 
was transplanted. By the time of the ASA meeting, 8 of the 10 recipients had 
died. A ninth, who was only 90 days postoperative, succumbed shortly 
thereafter. The only bright note was the first-ever one year survival of an insulin-
free pancreas reCipient. However, this patient also died just after passing the 
one year milestone. 
I was at that ASA meeting. In part because I was the next speaker on the 
program, I was concerned with what I perceived to be a sullen, if not frankly 
hostile, audience. When Lillehei finished, there was almost no applause, and 
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only 2 discussions (both of which were recorded and published [2]). The 
inference from the first discussion by John Brooks from the Brigham was that the 
Boston group did not believe that pancreas transplantation, upon which they also 
were working, was well enough developed to warrant a clinical trial. The other 
discussant was John Connolly from Irvine, California. He commended Dr. 
Lillehei for "his ingenuity and possible (sic) foresight in initiating pancreatic 
transplantation". Connolly also recommended, ". . . trimming the donor 
duodenum down to a tuft for anastomosis to recipient bowel." 
I knew Rich Lillehei well enough to realize how shaken he was by this and 
his subsequent experience with the procedure. He performed 3 more whole 
organ pancreas transplants during the next 3 years, none with companion 
kidneys (4). In the last case, the' donor duodenum was discarded except for a 
patch surrounding the ampulla of Vater as had been suggested by Connolly at 
the ASA meeting (discussion of [2]). When these last 3 grafts were rejected or 
were lost to vascular thrombosis, an end had come to what David Sutherland has 
called "Epoch Zero (i.e. The Prehistorical Epoch)" of the Minnesota experience. 
A 5 year moratorium was self-imposed by the Minneapolis team. 
Segmental Pancreas Transplant Pioneers 
During the 5 years of the Minnesota moratorium, the concept of whole 
organ transplantation was abandoned, or even villainized, worldwide. However, 
the use of segmental grafts kept the embers of pancreas transplantation alive: 
Gliedman in New York (5), Lagardier in Zurich (6), Groth in Sweden (7), and 
Dubernard in Lyon (8). With the assumption that enteric exocrine drainage was 
the principal lethal risk, various strategies were developed to divert the exocrine 
secretions of the segmental grafts into extra-alimentary channels (for example, 
host ureter or peritoneal cavity) or to block the secretions with polymer injections. 
Abandonment of enteric drainage was resisted mainly in Stockholm by Groth 
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(7,9) but also by Largardier in Zurich (6). The techniques used in Stockholm all 
involved drainage into host jejunal Roux limbs (10). 
The Resurrection 
The 8 years of David Sutherland's "historical Epoch 1" began with 
resumption of the Minnesota program and were bracketed by 1 978 and 1986. 
After the seminal trial by Caine in Cambridge (11), cyclosporine became 
available in selected centers in 1980. After testing the new drug in Pittsburgh in 
Lillehei's canine pancreas transplant models, we concluded our 1984· 
experimental report (12) with the following sentence: "We suggest that 
pancreaticoduodenal transplantation, which was abandoned 10 years ago, be 
reconsidered for clinical application. " 
In fact, the first 2 human recipients in our clinical report of 1984 (1) had 
been treated in early 1983. We drained the exocrine secretions through the graft 
duodenal C-Ioop and a short segment of jejunum into the host jejunum. Except 
for the graft jejunum, the Roux limb was the same as in Lillehei's procedure 
(Figure 1A,B). The spleen was included with the pancreas in one of these cases 
(Figure 1 A), but later removed because of hypersplenism. Both patients 
developed episodic fevers, cramps, watery diarrhea, a protein-losing 
enteropathy, hypoalbuminemia, and anemia (1). Some of these complaints 
resembled the blind loop syndrome that I had studied 25 years earlier, including 
in patients with stagnant Roux limbs following gastric surgery (13). 
Because of these similarities, and because we also were exploring the 
possibility of intestinal transplantation, the grossly normal Roux limb of the graft 
was detached for physiologic studies and anastomosed to the skin (Figure 1 C). 
Over the next 42 days, the daily ostomy output was 2 to 3 liters, containing up to 
20 grams per liter albumin (1). The total loss of 40 to 60 grams per day of 
endogenous albumin exceeded that of a lethal nephrotic syndrome in a patient 
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with kidney disease. Endoscopic biopsies of the allograft duodenum revealed 
mucosal damage, acute and chronic inflammation, and ulcerations, with minimal 
or no involvement of the muscularis or serosa. 
In addition to its metabolic consequences, the duodenum was an obvious 
entry site for microorganisms. All of the graft bowel was removed except for a 
duodenal bubble that was anastomosed to the host jejunum (Figure 1 D). The 
same revision was then done in the second patient. Both recipients were 
promptly relieved of their problems. All further patients had duodenal bubbles 
from the outset (1 ,14 ). 
Dissemination of the Whole Pancreas Procedure 
I presented our whole pancreas transplant cases in a peripheral session at 
the First International Symposium on Cyclosporine, hosted by Barry Kahan in 
Houston in May 1983. In his scholarly historical account, Sutherland described 
the prompt action taken by the Minnesota team: "By mid-1983, we stopped 
doing cadaver segmental grafts as a routine and returned to the whole pancreas 
technique (with papilla of Vater) used by Lillehei in his last case. We performed 
only a few cases by this technique before following the lead of Starzl et al at 
Pittsburgh to include the entire duodenum, as originally described by Lillehei." 
(15). The last 7 words were slightly confusing since the duodenal bubble, rather 
than the entire duodenum, was what was meant. 
Because pancreas transplantation, whether segmental or whole, had been 
opposed by our Pittsburgh Department of Medicine, the number of cases done in 
Pittsburgh was small. Thus, the reinstitution of whole organ transplantation in 
Minnesota was a critical step in disseminating the use of the operation. Spread 
of the procedure also was strongly influenced by 2 men who had scrubbed on 
our 1983-84 operations. One was a transplant fellow, Munci Kalayoglu, who 
subsequently joined Hans Sollinger at the University of Wisconsin. In Madison, 
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Sollinger had compiled a discouraging series of segmental pancreas 
transplantations in which exocrine secretions were drained by duct anastomosis 
to the bladder (16). After Kalayoglu's arrival in Madison, whole organ 
transplantation was adopted (17). However, exocrine secretions were drained 
into the urinary tract by connecting a patch of duodenum surrounding the ampulla 
of Vater to the bladder. 
The second export of the Pittsburgh experience was via Robb Corry who 
had been on a sabbatical leave in Pittsburgh to gear up for a new liver transplant 
program at the University of Iowa. As a bonus, Corry participated in several 
pancreaticoduodenal transplantations and applied this whole organ operation 
immediately after he returned home to Iowa City. For the first year and a half, 
Corry drained the duodenal bubble into the jejunum, just as he had seen in 
Pittsburgh (18). But in subsequent cases, the Iowa group anastomosed the 
duodenal bubble to the bladder (19). As recalled by Nghiem (20), the switch to 
bladder drainage in Iowa was undertaken independently by him while Corry was 
on temporary leave in West Virginia. 
Interactions between the Iowa City, Madison, and Minneapolis groups 
ensued that can be best appreciated by perusal of Groth's textbook, Pancreatic 
Transplantation (1988), to which all 3 teams contributed. In the Wisconsin 
chapter, Sollinger was still using a patch of duodenum for bladder anastomosis 
(21), but shortly afterwards, converted to use of the duodenal bubble (22). In his 
1993 report to the American Surgical Association, Sollinger noted that this 
bladder technique had spread like wildfire and was being employed in 71 United 
States pancreas transplant centers (23). Minnesota was no exception. In the 
Minnesota chapter of Groth's 1988 book, Sutherland et al stated that, "We have 
not used enteric drainage for a cadaver pancreas graft since June 1986 and 
have nearly completely converted to the use of a bladder technique for transplant 
from cadaver donors. " (24). 
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Despite the unwavering advocacy of enteric drainage by Groth (7 9, 10, 
and discussion of ref [23]), bladder drainage retained dominance for more than a 
decade. Because of a myriad of problems necessitating conversion to enteric 
drainage (scrupulously reported by Sollinger [23]), enthusiasm for bladder 
drainage began to diminish by the early 1990s. By then, Corry (now on the 
University of Pittsburgh faculty) switched back to enteric drainage of the 
duodenal bubble (25) and became the first proponent of tacrolimus for pancreas 
transplantation (26,27). Coinciding with the widespread acceptance of 
tacrolimus, enteric drainage became the reconstruction of choice at the pioneer 
centers and most others (15,28). 
Pancreaticoduodenal Transplantation: 
A Finished Product? 
Can we conclude that the pancreaticoduodenal operation has finally been 
standardized? Not really. It is well known that first pass exposure of the liver to 
insulin is critical for normal glucose homeostasis. Insulin also is essential for 
maintenance of liver size, ultrastructure, function, and the capacity for 
regeneration (29-32). To confer these so-called "hepatotrophic" benefits of 
insulin upon a co-transplanted liver, a cardinal principle in liver transplantation, 
and in the various multiple abdominal organ transplant procedures shown in 
Figure 2, is to drain the venous blood from the native pancreas or from a co-
transplanted pancreas into the portal or mesenteric vein. 
Because a significant number of liver recipients have preexisting Type I 
diabetes, it is surprising that less than a dozen cases have been reported of 
pancreas transplantation in diabetic liver recipients (33). In the first case, a 
polymer-injected segmental graft was transplanted in the pelvic location by Roy 
Caine on October 3, 1979, with systemic venous drainage (11). The pancreas 
failed at one year, but the patient lived for another 5 years before dying of liver 
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failure. Nine years passed before the second combined liver-pancreas 
procedure was performed on July 1,1988 in Pittsburgh (34). 
The Pittsburgh patient was a 40 year old male with end stage chronic HBV 
hepatitis who had been on 70 units/day insulin for many years. After hepatic 
replacement with conventional techniques (Figure 3, above transverse line), the 
donor's pancreas was arterialized below the transverse mesocolon with a Carrel 
patch (Figure 3, bottom). For the first time to our knowledge, the venous blood 
from a whole pancreas graft was drained into the portal bed (in this case via the 
host superior mesenteric vein) (Figure 3). Despite recurrent hepatitis, the patient 
is well and is insulin-free after 18-1/2 years (34). A second noteworthy feature of 
this operation was that all of the graft duodenum and a short piece of donor 
jejunum were retained and used as a Roux limb that was emptied with the 
proximal and distal enteric anastomoses as shown in Figure 3. 
The Roux limb was no longer an Achilles heel for the simple reason that it 
was protected from immune injury by the better immunosuppression that had 
become available with cyclosporine. This conclusion, which was tentatively 
reached with the case shown in Figure 3, was verified later in 1988 and 1989 in a 
series of cancer patients who had removal of all upper abdominal organs, 
followed by en bloc liver and pancreas replacement (35). In some of these 
cases, the duodenal loop and downstream jejunum were used as a Roux limb, as 
in Figure 3. But in others, the allograft bowel became part of the mainstream 
gastrointestinal track (Figure 4). These were the first-ever examples of truly long 
survival of a functional bowel allograft in a human recipient. Despite a high rate 
of tumor recurrence (33), several of these patients are still alive and insulin free 
more than 18 years later. 
The observations made with the operations shown in Figures 3 and 4 
demonstrated the remarkable versatility of the pancreaticoduodenal graft, with or 
without a jejunal extension. The use of the whole pancreas in continuity with a 
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liver allograft (Figure 4) is rarely used today for cancer treatment. However, this 
en bloc procedure has had its own recent resurrection for the treatment of Type I 
diabetics who also need liver replacement for non-neoplastic hepatic disease. 
The operation was used recently for this purpose by Pirenne et al (33) in 
Brussels and by Young et al (36) in Leeds. The only difference from the cancer 
operation is that the pancreaticoduodenal graft is layered on top of the native 
pancreas and duodenum which are not removed. In these operations (Figures 3 
and 4) and in the more complex multiple organ procedures shown in Figure 2, 
the pancreatic venous drainage goes straight to the liver. The exocrine 
secretions are emptied into the host duodenum or jejunum by the Roux limb 
originally described by Lillehei. 
The Physiologic Liability 
Of Abnormal Anatomy 
Widespread acceptance that non-physiologic exocrine drainage of 
pancreas grafts was not a desirable option required nearly a quarter century. A 
similar but more subtle question about pancreas transplantation concerns the 
optimal route of the allograft's venous drainage. Concerns of the liver surgeon 
about pancreatic venous drainage have, of course, been largely focused on the 
welfare of the co-transplanted liver (29-32). Any such discussion may also be 
relevant to the long term health of diabetic recipients of pancreas-only or 
pancreas-kidney transplantation. After a portacaval shunt in non-transplant 
patients, there are major pathologic changes in the liver (37), similar to these 
caused by this procedure in dogs, baboons, and other animals (38) (Figure 5). 
With electron microscopic (EM) studies obtained only a few days after portacaval 
shunt, only a few fragments of rough endoplasmic reticulum can be found in the 
shrunken hepatocytes. These and other ultrastructural changes correlate with 
wide-ranging losses of liver function. The association of these abnormalities with 
diversion of endogenous insulin around the liver has been demonstrated with 
simple experiments in dogs and other species (29-32, 38,39). 
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The liver cannot survive for long without insulin. With systemic venous 
drainage of the pancreas, this need is met (albeit sub-optimally) by the 
immediate development of arterial hyperinsulinemia, the maintenance of which 
theoretically could exhaust a transplanted pancreas. The metabolic penalties of 
placing the pancreas in a non-anatomic location go far beyond the simple loss of 
normal glucose homeostasis. Not surprisingly, systemic drainage of the 
transplanted pancreas has been associated by some members of this audience 
with dyslipidemia, accelerated atherosclerosis, and insulin resistance (40). In 
turn, insulin resistance is thought to be a seminal factor in nonalcoholic 
steatohepatitis syndromes (NASH liver disease) (41), the first stages of which 
have hepatic lipid accumulation similar to that shown in Figure 5 (mid panel). 
Formal assessment of such metabolic derangements would require very long 
follow-ups --- perhaps decades. Studies of this kind in systemically-drained 
pancreas recipients have not been done. 
The Foundation Laid by Lillehei 
It is only appropriate to conclude these historical remarks by returning to 
Rich Lillehei. His death in 1981 was particularly tragic because he never saw the 
fruits of his grand vision, and especially the ultimate vindication of his whole 
pancreas operation. In his ASA report of 1970 (2), Lillehei ascribed about half of 
the deaths to idiosyncratic events: for example contaminated ALG, a stroke, 
electrolyte imbalance, etc. However, he ultimately came to believe that the 
problems were more those of bowel transplantation than of the pancreas per se. 
This was evidenced by his elimination of everything but the duodenal patch in his 
last case. 
lillehei's insight is easier to understand if we bear in mind that he also 
was the modern forerunner of intestinal transplantation. Nearly 50 years ago, 
and 11 years before his epochal 1970 pancreas paper, lillehei brought his 
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studies of canine intestinal transplantation to the altar of the American Surgical 
Association, with an equally cool reception (42). Forewarned, Owen 
Wangensteen (Lillehei's chairman) pre-empted opposition with a memorable 
quotation. There may be those who might suggest that this work represents only 
a stunt. I will remind you that Benjamin Franklin once asked in passing judgment 
upon the promise of a matter of debatable merit: "What is the good of a newborn 
baby?" Well, who can tell? 
Lillehei's misfortune was that by arriving a decade too early, he 
encountered the insurmountable obstacle to intestinal and pancreas 
transplantation: i.e. inadequate immunosuppression. It was bad enough to die 
so young, but the worst heartbreak was to die disappointed. I skied with Lillehei 
from time to time in Colorado during the 1960s and 1970s. Once, in a darker 
moment, he ruefully remarked that he might have really accomplished something 
if only he had concentrated on fields less frustrating than pancreas and intestinal 
transplantation. Of course, this historical meeting is a living testament to how 
much he actually did accomplish. 
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FIGURE LEGENDS 
Figure 1 --- Pancreaticoduodenal transplantation performed in 2 patients 
(top left and right) in early 1983. The spleen was included in the first case, but 
removed 6-1/2 days later. The graft jejunal limb was detached and brought to 
the skin in patient 1 (bottom left), and in both cases was subsequently converted 
to a duodenal bubble (bottom right). The duodenal bubble was constructed at 
the outset all subsequent cases. 
Figure 2 --- Different multiple abdominal visceral (multivisceral) 
procedures in which a transplanted or native pancreas has venous drainage into 
the splanchnic venous bed. 
Figure 3 --- The liver-pancreas transplant operation performed on 1 July 
1988. Key features included the interposition of the transverse mesocolon 
between the 2 separately revascularized organs, delivery of the pancreas graft 
venous outflow into the host superior mesenteric vein (SMV), and the method of 
enteric drainage of pancreatic exocrine secretions. With slight modifications (e.g. 
double exocrine drainage is not necessary), the pancreas engraftment technique 
could be used to test the value of portal pancreatic venous drainage in pancreas-
alone or pancreas-kidney recipients. PV: portal vein. IVC: interior vena cava. 
(By permission of Harary et al: Liver Transplantation, 2007) 
Figure 4 --- (Left) Gastrointestinal series obtained in a patient treated 
with upper abdominal exenteration in 1988. Note that the homograft duodenum 
and a short segment of jejunum are in continuity with the patient's own stomach 
and jejunum. (Right) Technique used. To preserve the recipient celiac axis and 
left gastric artery, it was necessary to place the donor Carrel patch below the left 
renal vein and the recipient superior mesenteric artery. 
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Figure 5 --- Photomicrographs of sections from a baboon liver subjected 
to portal diversion. The panels on the left show the liver structure as seen in a 
biopsy immediately before portacaval anastomosis. The panels on the right 
show the condensation of lobular reticulin, accumulation of fat and atrophy of 
hepatocytes 208 days after operation. (Top) reticulin stain, X20; (middle), frozen 
section stained with Sudan, 4, x30; (Bottom), and E, x175. 
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